Effects of trastuzumab deruxtecan (T-DXd) on health-related quality of life (HRQOL): DESTINY-Breast12 (DB-12) results Dr Grinshpun on Ultra-Sensitive ctDNA Detection in HR+ Early Breast Cancer Dr Mayer on Niraparib Plus Dostarlimab in ER+ BRCA/PALB2-Mutated Breast Cancer ...
cancer (TNBC), new data on immunotherapy in combination with chemotherapy, the role of capecitabine, the potential of circulating tumor DNA as apredictive tool in the postneoadjuvant setting and new treatment approaches were presented and discussed at the San Antonio Breast Cancer Symposium (SABCS) ...
For patients with early-stage breast cancer who are considered high-risk for distant disease recurrence and risk of death, the use of pCR an measure of clinical efficacy may predict clinical benefit within several months of treatment, addressing unmet treatment needs in a shorter timeframe compared...
948 USE OF A DECISION AID REGARDING TREATMENT OPTIONS FOR EARLY PROSTATE CANCER: A SINGLE-INSTITUTIONAL REPORT ON PATTERN OF TREATMENT CHOICE IN 230 PATIENTS Purpose: To evaluate outcomes of low-risk prostate cancer patients managed with competing treatments, in a single institution. Methods: Patients...
EP: 1.Optimizing Adherence to CDK4/6 Inhibitors in Metastatic Breast Cancer EP: 2.Institutional Insights on CDK4/6 Inhibitor Adherence in Breast Cancer EP: 3.CDK4/6 Inhibitors as First-Line Options in Metastatic Breast Cancer EP: 4.Treatment Algorithms for Early and Metastatic Breast Cancer EP...
Mammograms are one of the best forms of prevention and early detection of breast cancer. Women at average risk of breast cancer should begin mammogram screening
CancerIQ makes it easy for health systems to use genetic information to get ahead of cancer at scale. Our best-in-class, science-based platform is proven to double genetic counseling service capacity, quadruple genetic testing uptake & significantly impr
Access that does not jeopardize the pathway to broad long-term access and approvals through local health systems. Access that minimizes burden on healthcare systems, HCPs, patients, and families. Science & Innovation Pipeline Medical Professionals ...
The treatment paradigms of early-stage and metastatic lung cancer have expanded significantly in recent years with the addition of immunotherapy and targeted therapy options, said Brendon Stiles, MD, who added that challenges regarding screening, molecular testing, and localized therapy remain areas of ...
et al. Reflecting on 20 years of breast cancer modeling in CISNET: recommendations for future cancer systems modeling efforts. PLoS Comput. Biol. 17, e1009020 (2021). Article CAS PubMed PubMed Central Google Scholar Shieh, Y. et al. Breast cancer screening in the precision medicine era:...